Embolization treatment
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
280
NCT04523350
Instylla HES Hypervascular Tumor Pivotal Study
Phase: N/A
Role: Lead Sponsor
Start: Jan 4, 2021
Completion: Nov 19, 2024
NCT05364502
(HALT) Embrace Hydrogel Embolic System (HES) Study of Embolization in Peripheral Arterial Bleeds
Start: Dec 12, 2022
Completion: Mar 31, 2026
Loading map...